IPCA Laboratories · NSE: IPCALAB · BSE: 524494
Q3 FY19 results · Oct–Dec 2018
IPCA Laboratories reported revenue from operations of ₹947.59 crore and net profit of ₹160.18 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 947.59 | — | — | 997.82 | −5.0% |
| Other income | 12.63 | — | — | 13.75 | −8.1% |
| Total income | 960.22 | — | — | 1,011.57 | −5.1% |
| Profit before tax | 196.78 | — | — | 141.00 | +39.6% |
| Net profit for the period | 160.18 | — | — | 119.74 | +33.8% |
| EPS, basic (₹) | 12.68 | — | — | 9.48 | +33.8% |
| Net margin (%) | 16.9 | — | 12.0 |
Standalone
- Filed with BSE
- 12 Feb 2019, 18:34 IST
- Board meeting
- 12 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE